Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 11/20 | 0.82 |
| ▸ | HSD17B10 | Q99714 | 8/20 | 0.82 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.82 |
| ▸ | TP53 | P04637 | 2/20 | 0.82 |
| ▸ | HPGD | P15428 | 1/20 | 0.82 |
| ▸ | MAPT | P10636 | 9/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.77 |
| ▸ | GAA | P10253 | 7/20 | 0.77 |
| ▸ | LMNA | P02545 | 4/20 | 0.77 |
| ▸ | HTR3A | P46098 | 3/20 | 0.67 |
| ▸ | HTT | P42858 | 3/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | GLA | P06280 | 3/20 | 0.64 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13091079 | 0.91 | HTR3A (0.79) | ALDH1A1HSD17B10SMN1; SMN2TP53HPGD | |
| SCHEMBL13942456 | 0.90 | HSD17B10 (0.83) | ALDH1A1HSD17B10SMN1; SMN2TP53HPGD | |
| SCHEMBL13091081 | 0.87 | HSD17B10 (0.79) | ALDH1A1HSD17B10SMN1; SMN2TP53HPGD | |
| SCHEMBL13091075 | 0.86 | ALDH1A1 (0.84) | ALDH1A1HSD17B10SMN1; SMN2TP53HPGD | |
| SCHEMBL13091015 | 0.85 | GAA (0.85) | ALDH1A1HSD17B10SMN1; SMN2TP53HPGD | |
| SCHEMBL13091076 | 0.84 | MAPT (0.79) | ALDH1A1HSD17B10SMN1; SMN2TP53HPGD | |
| SCHEMBL13091078 | 0.83 | HTR3A (0.74) | ALDH1A1HSD17B10SMN1; SMN2TP53HPGD | |
| SCHEMBL13091072 | 0.81 | ALDH1A1 (0.84) | ALDH1A1HSD17B10SMN1; SMN2TP53HPGD | |
| SCHEMBL13091099 | 0.81 | ALDH1A1 (0.84) | ALDH1A1HSD17B10SMN1; SMN2TP53HPGD | |
| SCHEMBL8230064 | 0.80 | HTR3A (1.00) | ALDH1A1HSD17B10SMN1; SMN2TP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2194783-B1 | COMPOSITIONS AND METHODS FOR APOPTOSIS MODULATORS | VM DISCOVERY INC (US) | 2017-07-05 | — | — | EP | disclosed |
| US-20100267671-A1 | COMPOSITIONS AND METHODS FOR APOPTOSIS MODULATORS | VM DISCOVERY INC. | 2010-10-21 | — | — | US | disclosed |
| US-20100267671-A1 | COMPOSITIONS AND METHODS FOR APOPTOSIS MODULATORS | VM DISCOVERY INC. | 2010-10-21 | — | — | US | disclosed |
| WO-2009023558-A1 | COMPOSITIONS AND METHODS FOR APOPTOSIS MODULATORS | VM DISCOVERY INC. (US) | 2009-02-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267671-A1 | COMPOSITIONS AND METHODS FOR APOPTOSIS MODULATORS | BAX, BCL2, BAD | ALDH1A1 3966/4885HSD17B10 2550/4885SMN1; SMN2 1154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.